370 likes | 389 Views
This guide covers different types of adrenoceptor antagonists, including α- and β-receptor antagonists, their pharmacological effects, clinical uses, and adverse effects. It also discusses representative drugs and their implications in various disorders.
E N D
Part 5Adrenoceptor Antagonists 1. receptor antagonists 2. receptor antagonists 3. , receptor antagonists
1. receptor antagonists • 1-1 1, 2 receptor antagonists • Short-acting Phentolamine 酚妥拉明
1. receptor antagonists • 1.1 Pharmacology • (1) Vasodilatation • Blocking 1 receptor; direct action • (2) Stimulating heart • Reflex;blocking 2 receptor ~NE release • (3) Cholinergic and histamine-like effects • Contraction of GI smooth muscles, • Gastric acid secretion
1. receptor antagonists • 1.2 Clinical uses • (1) Peripheral vascular diseases • Acrocyanosis, Raynaud’s disease • (2) Local vasoconstrictor extravasation
1. receptor antagonists • (3) Shock • cardiac output ; • redistribution of blood flow; • shift of fluid from interstitial compartment to vascular compartment; • pulmonary pressure ; • should be used after fully adequate replacement of intravascular fluid
1. receptor antagonists • (4) Acute myocardial infarction and congestive heart failure • after-load ; cardiac output
1. receptor antagonists • (5) Pheochromocytoma • pre- and post-operation uses • diagnosis • (6) Others: impotency (阳痿)
1. receptor antagonists • 1.3 Adverse effects • (1) Postural hypotension • (2) Reflex heart stimulation • tachycardia, arrhythmia, angina pectoris • (3) G.I. reactions • (4) Other • central depression
1. receptor antagonists • Tolazoline妥拉唑啉 • weak effects • more severe adverse effects
1. receptor antagonists • Long-acting • Longer action duration • used for peripheral vasculardiseases • anti-shock • pheochromocytoma • improving urinary flow in patients with benign prostatic hypertrophy Phenoxybenzamine 酚苄明
1. receptor antagonists • 1-2 1 receptor antagonists • prazosin(哌唑嗪), for hypertension treatment • tamsulosin(坦洛新), for benign prostatic hypertrophy • 1-3 2 receptor antagonists • yohimbine(育亨宾)
2. receptor antagonists • 2.1 ADME • First-pass elimination, • lower bioavailability: propranolol • Hepatic metabolism and renal excretion, hepatic and renal functions alter the effects of the drugs and result in large individual variation • Thus, dose individualization is necessary.
2. receptor antagonists • 2.2 Pharmacological effects • (1) receptor blockade • A. Cardiovascular effects: • Depressing heart: reduction in HR, A-V conduction, automaticity, cardiac output, oxygen consumption • Hypotension: hypotensive effects only in hypertensive patients; peripheral blood flow , BP in normal subjects.
Blockade of –adrenoceptor cardial responses by propranolol
2. receptor antagonists • B. Bronchial smooth muscles • inducing bronchial smooth muscle contraction in asthmatic patients • C. Metabolism • lipolysis , glycogenolysis , potentiating insulin effects ~ hypoglycemia • D. Renin secretion • decreasing secretion of renin
2. receptor antagonists • (2) Intrinsic sympathomimetic effects • Some drugs: HR , output • (3) Membrane-stabilizing effects • Larger doses of some drugs: quinidine-like effects due to Na+ channel block • (4) Others • Lowering intraocular pressure; • Inhibiting platelet aggregation
2. receptor antagonists • 2.3 Clinical uses • (1) Arrhythmia:supraventricular, sympathetic activity • (2) Hypertension • (3) Angina pectoris and myocardial infarction • (4) Chronic heart failure • (5) Others: hyperthyroidism, migraine headache, glaucoma(timolol), etc.
Effect of a receptor antagonist on the mortality of chronic heart failure
2. receptor antagonists • 2.4 Adverse effects • (1) Worsening of asthma: contraindicated in bronchial asthmatic patients • (2) Heart depression: contraindicated in heart failure, severe A-V block, sinus bradycardia • (3) Worsening of peripheral vascular constriction • (4) Withdrawal syndrome:up-regulation of receptors • (5) Others:central depression, hypoglycemia, etc.
2. receptor antagonists • 2.5 Representative drugs Propranolol 普萘洛尔
2. receptor antagonists • 1, 2 receptor blocking • no intrinsic activity • first-elimination after oral administration, individual variation of bioavailability Propranolol 普萘洛尔
2. receptor antagonists Timolol 噻马洛尔 • For treatment of glaucoma (wide-angle)
2. receptor antagonists Atenolol 阿替洛尔 Metoprolol 美托洛尔 • 1 receptor antagonists, no intrinsic activity • atenolol : longer t1/2, once daily • usually used for treatment of hypertension
3. α, receptor antagonists Labetolol 拉贝洛尔 • blockingα, β receptors, β> α • usually used for treatment of hypertension
3. α, receptor antagonists Carvedilol 卡维地洛 • α, β receptor blocking, β> α • S(-) isomer: βand α receptor blocking • R(+) isomer: α receptor blocking • usually used for treatment of hypertension and chronic heart failure
procaine 普鲁卡因 lidocaine 利多卡因 tetracaine 丁 卡 因
Local anesthetics • 1. Pharmacological effects • (1) Local anesthetic effects • inhibiting Na+ inward flow and the conduction of nerve fibers • sensory (fine – thick) CNS(inhibiting - excitatory) ANS motor nerves muscles
The mechanism of local anesthetics Blocking Na+ channels on the nerve fibers
The mechanism of local anesthetics Intracellular blockade of Na+ channel
Local anesthetics • (2) Systemic effects(Adverse effects) • Depressing CNS:excitation - depression • Cardiovascular effects:heart depression; vasodilatation; lowering BP • combined with epinephrine:reducing absorption and systemic effects • ( but contraindicated in: terminal tissues; epinephrine contraindications )
Local anesthetics • 2. Clinical uses • (1) Surface anesthesia (表面麻醉) • penetration • (2) Infiltration anesthesia (浸润麻醉) • (3) Conduction anesthesia (传导麻醉)
Local anesthetics • (4) Epidural anesthesia (硬脊膜外麻醉) • Avoiding misdirection into cerebrospinal fluid • (5) Subarachnoid anesthesia (蛛网膜下腔麻 • 醉 , 腰麻) • head-up position; • hyperbaric solution; • hypotension: prevention with ephedrine
Local anesthetics • 3. Adverse effects • (1) Systemic effects • depression of CNS: excitation – depression – respiratory depression • cardiovascular effects: hypotension; arrhythmia • (2) Allergic reactions • urticaria, bronchoconstriction; anaphylactic shock
Local anesthetics • 4. Special agents Efffect Toxicity Pene-Uses tration procaineweak weak weak can not be used 普鲁卡因(allergic) for surface skin allergic test lidocainestronger lower stronger for various uses; 利多卡因anti-arrhythmia tetracainestronger stronger stronger mainly for surface 丁卡因